Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
688581.SS
BUYREMOVEHangzhou AGS MedTech Co., Ltd. · Healthcare · China · $671M · Avg Vol: $8M/d
Hangzhou AGS MedTech is a high-quality medical device manufacturer (Q: 72) specializing in endoscopic instruments, but it does not align with our high-conviction CDMO pricing power or advanced packaging themes.
COMPANY DESCRIPTION
Hangzhou AGS MedTech Co., Ltd. develops and manufactures minimally invasive medical devices for endoscopic diagnosis and treatment, primarily targeting the gastrointestinal tract. The company offers a wide range of consumables, including biopsy forceps, injection needles, and hemostatic clips, competing directly with multinational medical device giants. Its competitive advantage lies in its cost-effective manufacturing, rapid product iteration, and expanding global distribution network across Europe and the Americas.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | 55M | 75M | 94M | 88M | 17.0% |
| EPS | 0.35 | 0.44 | 0.54 | 0.41 | 5.0% |
| Shares | 61M | 81M | 81M | 81M | +33.5% |
| Debt | 242,812 | 83,549 | 510,391 | 6M | 183.0% |
| Equity | 56M | 326M | 354M | 372M | 87.5% |
| Op CF | 23M | 33M | 47M | 22M | -1.1% |
| Inv CF | -18M | -11M | -167M | -13M | — |
| Fin CF | -6M | 236M | -16M | -8M | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 688581.SS are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 688581.SS | Hangzhou AGS MedTech Co., Ltd.(you) | $671M | 73 | BUY |
| 2172.HK | MicroPort NeuroScientific Corporation | $675M | 73 | BUY |
| 688389.SS | Shenzhen Lifotronic Technology Co., Ltd. | $745M | 68 | BUY |
| 2291.HK | LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. | $425M | 74 | BUY |
| 688236.SS | Beijing Chunlizhengda Medical Instruments Co., Ltd. | $920M | 69 | BUY |
| 1763.HK | China Isotope & Radiation Corporation | $734M | 85 | STRONG BUY |
| 2190.HK | Zylox-Tonbridge Medical Technology Co., Ltd. | $853M | 82 | STRONG BUY |
| 2235.HK | MicroTech Medical (Hangzhou) Co., Ltd. | $385M | 70 | BUY |
| 603387.SS | Getein Biotech, Inc | $668M | 90 | STRONG BUY |
| 1302.HK | LifeTech Scientific Corporation | $932M | 84 | STRONG BUY |
Peer medians: ROE 4.7% · P/E 27.9x · Gross margin 53.0%